Epstein-Barr virus infection resembling autoimmune hepatitis with lactate dehydrogenase and alkaline phosphatase anomaly

Journal of Gastroenterology

Volumn 34, Issue 6, 1999, Pages 706-712

  Kojima, Kyoko ^a   Nagayama, Ryozo ^a   Hirama, Sachio ^a   Maeda, Tomomi ^a   Takikawa, Hajime ^a   Miyake, Kazuhiko ^a   Yamanaka, Masami ^a   Shiga, Junji ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alkaline phosphatase anomaly; Autoimmune hepatitis; Autoimmunization; Epstein Barr virus infection; Lactate dehydrogenase anomaly

Indexed keywords

ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; LACTATE DEHYDROGENASE; VIRUS ANTIBODY;

AGED; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; CASE REPORT; DISEASE COURSE; EPSTEIN BARR VIRUS; FEVER; GRANULOCYTOPENIA; HUMAN; LIVER INJURY; LYMPHADENOPATHY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; RASH; THROMBOCYTOPENIA; VIRUS INFECTION;

EID: 0032787538     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050324     Document Type: Article

References (26)

1. Tobi M, Morag A, Ravid Z, Chowers I, Feldman Weiss V, Michaeli Y, et al. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982;I:61-3.
2. Rickinson AB. Chronic, symptomatic Epstein-Barr virus infection. Immunol Today 1986;7:13-4.
3. Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988;157:405-12.
4. Purtilo DT, Strobach RS, Okano M, Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992; 67:5-23.
5. Ishihara S, Hara J, Tawa A, Kawa-ha K. Chronic active EB virus infection and granular lymphocyte proliferative disorders in Japan (in Japanese with English abstract). Rinsho Ketueki (Jpn J Clin Hematol) 1996;37:280-7.
6. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112-9.
7. Hironaka T, Nagasaki M, Morikawa S, Hirai K. Detection of Epstein-Barr virus transcripts in chemically or immunologically activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. J Virol Methods 1993;40:141-54.
8. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 1989;169:2191-8.
9. Cohen JI. Epstein-Barr virus and the immune system. JAMA 1997;278:510-3.
10. Gan YJ, Sullivan JL, Sixbey JW. Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis 1994;170:436-9.
11. Rapp CD Jr, Hewetson JF. Infectious mononucleosis and the Epstein-Barr virus. Am J Dis Child 1978;132:78-86.
12. Pullen H, Wright N, Murdoch JM. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet 1967;I: 1176-8.
13. Olson GB, Kanaan MN, Gersuk GM, Kelley LM, Jones JF. Correlation between allergy and persistent Epstein-Barr virus infection in chronic-active Epstein-Barr virus-infected patients. J Allergy Clin Immunol 1986;78:308-14.
14. Olson GB, Kanaan MN, Kelly LM, Jones JF. Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infection. J Allergy Clin Immunol 1986;78:315-20.
15. Nazareth IJ. Ampicillin and mononucleosis. BMJ 1971;III:48.
16. Yamamoto K, Hattori Y. Double anomaly of enzyme-immunoglobulin complex (in Japanese). Med Biol 1984;109:121-4.
17. James JA, Kaufman KM, Farris AD, Taylor Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-26.
18. Wen S, Shimizu N, Yoshiyama H, Mizugaki Y, Shinozaki F, Takada K. Association of Epstein-Barr virus (EBV) with Sjögren syndrome. Differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol 1996;149:1511-7.
19. Vaugham JH, Valbracht JR, Nguyen MD, Handley HH, Smith RS, Patrick K, et al. Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J Clin Invest 1995;95:1306-15.
20. Vaugham JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest 1995;95: 1316-27.
21. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 1992;327:1710-4.
22. Yatabe Y, Mori N, Oka K, Ijima T, Saga S, Takada K, Asai J. Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood. Arch Pathol Lab Med 1995;119:409-17.
23. Vento S, Guella L, Mirandola F, Cainelli F, DiPerri G, Solbiati M, et al. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 1995;346:608-9.
24. Treichel U, Poralla T, Hess G, Manns M, Meyer zum Büschenfelde KH. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 1990;11:606-12.
25. Pipp ML, Means ND, Sixbey JW, Morris KL, Gue CL, Baddour LM. Acute Epstein-Barr virus infection complicated by severe thrombocytopenia. Clin Infect Dis 1997;25:1237-9.
26. Schooley RT, Densen P, Harmon D, Felsenstein D, Hirsch MS, Henle W, Weitzman S. Antineutrophil antibodies in infectious mononucleosis. Am J Med 1984;76:85-90.